Edward M. Kaye
2022 - Stoke Therapeutics
In 2022, Edward M. Kaye earned a total compensation of $5.7M as Chief Executive Officer at Stoke Therapeutics, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $32,293 |
|---|---|
| Non-Equity Incentive Plan | $290,636 |
| Option Awards | $4,817,310 |
| Salary | $596,083 |
| Other | $12,200 |
| Total | $5,748,522 |
Kaye received $4.8M in option awards, accounting for 84% of the total pay in 2022.
Kaye also received $32.3K in bonus, $290.6K in non-equity incentive plan, $596.1K in salary and $12.2K in other compensation.
Rankings
In 2022, Edward M. Kaye's compensation ranked 536th out of 5,717 executives tracked by ExecPay. In other words, Kaye earned more than 90.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 536 out of 5,717 | 91st |
Division Manufacturing | 227 out of 3,111 | 93rd |
Major group Chemicals And Allied Products | 70 out of 1,410 | 95th |
Industry group Drugs | 58 out of 1,311 | 96th |
Industry Pharmaceutical Preparations | 42 out of 957 | 96th |
Source: SEC filing on September 28, 2023.
Kaye's colleagues
We found two more compensation records of executives who worked with Edward M. Kaye at Stoke Therapeutics in 2022.